1.A Reinforced Endotracheal Tube Completely Severed by a Patient Bite and Lodged in the Right Main Bronchus.
Susie YOON ; Hyunjung CHOO ; Se Eun KIM ; Heeyeon KWON ; Hannah LEE
Korean Journal of Critical Care Medicine 2017;32(1):70-73
Reinforced endotracheal tubes (ETTs) are designed to resist kinking or compression. However, these have a potential risk of being obstructed or severed by a patient's bite. We report a case in which a reinforced ETT was severed by tube-bite while the patient was in the prone position during an intensive care unit stay. Bronchoscopic evaluation showed that the severed distal part of the tube had lodged in the patient's right main bronchus, and it had to be surgically removed. The patency of reinforced ETTs should be carefully monitored in patients intubated in the prone position.
Airway Obstruction
;
Bronchi*
;
Bronchoscopy
;
Humans
;
Intensive Care Units
;
Intubation
;
Patient Rights
;
Prone Position
2.Plasmaphresis therapy for pulmonary hemorrhage in a pediatric patient with IgA nephropathy.
Dae Kyoon YIM ; Sang Taek LEE ; Heeyeon CHO
Korean Journal of Pediatrics 2015;58(10):402-405
IgA nephropathy usually presents as asymptomatic microscopic hematuria or proteinuria or episodic gross hematuria after upper respiratory infection. It is an uncommon cause of end-stage renal failure in childhood. Pulmonary hemorrhage associated with IgA nephropathy is an unusual life-threatening manifestation in pediatric patients and is usually treated with aggressive immunosuppression. Pulmonary hemorrhage and renal failure usually occur concurrently, and the pulmonary manifestation is believed to be caused by the same immune process. We present the case of a 14-year-old patient with IgA nephropathy who had already progressed to end-stage renal failure in spite of immunosuppression and presented with pulmonary hemorrhage during oral prednisone treatment. His lung disease was comparable to diffuse alveolar hemorrhage and was successfully treated with plasmapheresis followed by oral prednisone. This case suggests that pulmonary hemorrhage may develop independently of renal manifestation, and that plasmapheresis should be considered as adjunctive therapy to immunosuppressive medication for treating IgA nephropathy with pulmonary hemorrhage.
Adolescent
;
Glomerulonephritis, IGA*
;
Hematuria
;
Hemorrhage*
;
Humans
;
Immunoglobulin A*
;
Immunosuppression
;
Kidney Failure, Chronic
;
Lung Diseases
;
Plasmapheresis
;
Prednisone
;
Proteinuria
;
Renal Insufficiency
3.The Use of Nafamostat Mesilate as an Anticoagulant during Continuous Renal Replacement Therapy for Children with a High Risk of Bleeding.
Journal of the Korean Society of Pediatric Nephrology 2014;18(2):98-105
PURPOSE: Nafamostat mesilate (NM), a synthetic serine protease inhibitor, has been investigated as an anticoagulant for adult patients with a high risk of bleeding, who need chronic renal replacement therapy (CRRT). However, little is known about the use of NM as an anticoagulant in pediatric CRRT. The aim of this study was to evaluate the ideal dosage, efficacy, and safety of NM in pediatric CRRT. METHODS: We conducted a retrospective study of 40 pediatric patients who had undergone at least 24 h of venovenous CRRTs between January 2011 and October 2013. We divided the patients according to risk of bleeding. Those at high risk received no anticoagulation (group 1) or NM as an anticoagulant (group 2), while those at low risk received heparin (group 3). RESULTS: Forty patients (25 male and 15 female; mean age, 8.2+/-6.6 years) were enrolled. The mean duration of CRRT was 13.0 days, and the survival rate was 57.5%. The mean hemofilter lifespan was 39.3 h in group 1 and 11.3 h in group 3. In group 2, hemofilter lifespan was extended from 7.5 h to 27.4 h after the use of NM (P=0.001). The mean hemofilter lifespan with NM was greater than with heparin (P=0.018). No patient experienced a major bleeding event during treatment with NM. CONCLUSION: NM may be a good alternative anticoagulant in pediatric patients with a high risk of bleeding requiring CRRT, and is not associated with bleeding complications.
Adult
;
Child*
;
Female
;
Hemorrhage*
;
Heparin
;
Humans
;
Male
;
Mesylates*
;
Renal Replacement Therapy*
;
Retrospective Studies
;
Serine Proteases
;
Survival Rate
4.Burkholderia Cepacia Causing Nosocomial Urinary Tract Infection in Children.
Ki Wuk LEE ; Sang Taek LEE ; Heeyeon CHO
Childhood Kidney Diseases 2015;19(2):143-147
PURPOSE: Burkholderia cepacia is an aerobic, glucose-non-fermenting, gramnegative bacillus that mainly affects immunocompromised and hospitalized patients. Burkholderia cepacia has high levels of resistance to many antimicrobial agents, and therapeutic options are limited. The authors sought to analyze the incidence, clinical manifestation, risk factors, antimicrobial sensitivity and outcomes of B. cepacia urinary tract infection (UTI) in pediatric patients. METHODS: Pediatric patients with urine culture-proven B. cepacia UTI between January 2000 and December 2014 at Samsung Medical Center, a tertiary referral hospital in Seoul, Republic of Korea, were included in a retrospective analysis of medical records. RESULTS: Over 14 years, 14 patients (male-to-female ratio of 1:1) were diagnosed with B. cepacia UTI. Of 14 patients with UTI, 11 patients were admitted to the intensive care unit, and a bladder catheter was present in 9 patients when urine culture was positive for B. cepacia. Patients had multiple predisposing factors for UTI, including double-J catheter insertion (14.2%), vesico-ureteral reflux (28. 6%), congenital heart disease (28.6%), or malignancy (21.4%). Burkholderia cepacia isolates were sensitive to piperacillin-tazobactam and sulfamethoxazole-trimethoprim, and resistant to amikacin and colistin. Treatment with parenteral or oral antimicrobial agents including piperacillin-tazobactam, ceftazidime, meropenem, and sulfamethoxazole-trimethoprim resulted in complete recovery from UTI. CONCLUSION: Burkholderia cepacia may be a causative pathogen for nosocomial UTI in pediatric patients with predisposing factors, and appropriate selection of antimicrobial therapy is necessary because of high levels of resistance to empirical therapy, including aminoglycosides.
Amikacin
;
Aminoglycosides
;
Anti-Infective Agents
;
Bacillus
;
Burkholderia cepacia*
;
Burkholderia*
;
Catheters
;
Causality
;
Ceftazidime
;
Child*
;
Colistin
;
Heart Defects, Congenital
;
Humans
;
Incidence
;
Intensive Care Units
;
Medical Records
;
Republic of Korea
;
Retrospective Studies
;
Risk Factors
;
Seoul
;
Tertiary Care Centers
;
Urinary Bladder
;
Urinary Tract Infections*
;
Urinary Tract*
;
Vesico-Ureteral Reflux
5.Posterior reversible encephalopathy syndrome caused by presumed Takayasu arteritis.
Ki Wuk LEE ; Sang Taek LEE ; Heeyeon CHO
Korean Journal of Pediatrics 2016;59(Suppl 1):S145-S148
Takayasu arteritis (TA) is a chronic inflammatory disease of unknown etiology that affects mainly the aorta, main aortic branches, and pulmonary arteries. Diverse neurological manifestations of TA have rarely been reported in children. Posterior reversible encephalopathy syndrome (PRES) is a neuroradiological condition that presents with headache, seizure, visual disturbances, and characteristic lesions on imaging. Inflammatory condition and severe hypertension in TA can cause PRES. We report of a 5-year-old girl with presumed TA who presented with PRES and chronic total occlusion in the renal artery. The findings on magnetic resonance imaging suggested PRES. Left nephrectomy was performed for total occlusion of the left renal artery, and the confirmatory diagnosis of TA was based on the pathologic findings of the renal artery.
Aorta
;
Child
;
Child, Preschool
;
Diagnosis
;
Female
;
Headache
;
Humans
;
Hypertension
;
Magnetic Resonance Imaging
;
Nephrectomy
;
Neurologic Manifestations
;
Posterior Leukoencephalopathy Syndrome*
;
Pulmonary Artery
;
Renal Artery
;
Seizures
;
Takayasu Arteritis*
6.Acute kidney injury in pediatric patients with rhabdomyolysis.
Young Shin LIM ; Heeyeon CHO ; Sang Taek LEE ; Yeonhee LEE
Korean Journal of Pediatrics 2018;61(3):95-100
PURPOSE: This study aimed to evaluate the clinical findings in pediatric rhabdomyolysis and the predictive factors for acute kidney injury (AKI) in Korean children. METHODS: Medical records of 39 Korean children, who were newly diagnosed with rhabdomyolysis from January 2008 to December 2015, were retrospectively analyzed. The diagnosis was made from the medical history, elevated serum creatinine kinase level >1,000 IU/L, and plasma myoglobin level >150 ng/mL. Patients with muscular dystrophy and myocardial infarction were excluded. RESULTS: The median patient age at diagnosis was 14.0 years (range, 3–18 years), and the male to female ratio was 2.5. The most common presenting symptom was myalgia (n=25, 64.1%), and 14 patients (35.9%) had rhabdomyolysis-induced AKI. Eighteen patients (46.2%) had underlying diseases, such as epilepsy and psychotic disorders. Ten of these patients showed rhabdomyolysis-induced AKI. The common causes of rhabdomyolysis were infection (n=12, 30.7%), exercise (n=9, 23.1%), and trauma (n=8, 20.5%). There was no difference in the distribution of etiology between AKI and non-AKI groups. Five patients in the AKI group showed complete recovery of renal function after stopping renal replacement therapy. The median length of hospitalization was 7.0 days, and no mortality was reported. Compared with the non-AKI group, the AKI group showed higher levels of peak creatinine kinase and myoglobin, without statistical significance. CONCLUSION: The clinical characteristics of pediatric rhabdomyolysis differ from those observed in adult patients. Children with underlying diseases are more vulnerable to rhabdomyolysis-induced AKI. AKI more likely develops in the presence of a high degree of albuminuria.
Acute Kidney Injury*
;
Adult
;
Albuminuria
;
Child
;
Creatinine
;
Diagnosis
;
Epilepsy
;
Female
;
Hospitalization
;
Humans
;
Male
;
Medical Records
;
Mortality
;
Muscular Dystrophies
;
Myalgia
;
Myocardial Infarction
;
Myoglobin
;
Phosphotransferases
;
Plasma
;
Psychotic Disorders
;
Renal Replacement Therapy
;
Retrospective Studies
;
Rhabdomyolysis*
7.Bleomycin Intralesional Injection in Keloids and Hypertrophic Scars Unresponsive to Previous Corticosteroid Intralesional Injection and/or Laser Treatment:A Case Series and Review of the Literature
Hyungrye NOH ; Heeyeon KIM ; Joonho SHIM ; Se Jin OH ; Jihye PARK ; Dongyoun LEE ; Jong Hee LEE
Korean Journal of Dermatology 2023;61(7):437-442
The treatment of pathological scars, such as keloids and hypertrophic scars, can be challenging for dermatologists. The first-line treatment is intralesional corticosteroid injection, especially when patients complain of pain or discomfort. Laser treatment can also be used in patients with keloids and hypertrophic scars. However, even after multiple sessions of intralesional corticosteroid injections and laser treatment, desirable outcomes may not be achieved, and recurrence is common. Recent studies on the efficacy of intralesional bleomycin injection (BLMILI) in treating keloids and hypertrophic scars have suggested that a significant improvement is observed after BLMILI. However, there is limited research on the effectiveness of BLMILI for patients who do not respond to other treatments, such as intralesional corticosteroid injection or laser treatment. Here, we report four cases of BLMILI in keloids and hypertrophic scars that were unresponsive to previous intralesional corticosteroid injection and/or laser treatment.
8.Publication of the Korea-WHO Cooperation History — 70 Years of Working Together for Heath: World Health Organization and the Republic of Korea.
Heeyeon CHO ; Dong Woo LEE ; Young June CHOE ; Seung Ah CHOE ; No Yai PARK
Journal of Korean Medical Science 2017;32(3):383-385
The World Health Organization (WHO) have been in collaborative efforts with the Republic of Korea in keeping of and for better health for all for the past decades. From the control of parasites to building of community health system in rural places, the works has now resulted in healthier Korea than ever, and has transformed the role of engaging as the world leader in contribution of health and development. Seventy years of independence, war, and poverty, transforming from a recipient country of official development assistance to a significant donor to the global society, we have emphasized the importance of international cooperation and the role of WHO in the past years in Korea and neighboring countries. Looking back of the past is meaningful to diagnose the present problems, and to foresee the future of our world.
Community Health Planning
;
Global Health*
;
Humans
;
International Cooperation
;
Korea
;
Parasites
;
Poverty
;
Public Health
;
Publications*
;
Republic of Korea*
;
Tissue Donors
;
World Health Organization*
9.A novel mutation of CLCNKB in a Korean patient of mixed phenotype of Bartter-Gitelman syndrome.
Hee Won CHO ; Sang Taek LEE ; Heeyeon CHO ; Hae Il CHEONG
Korean Journal of Pediatrics 2016;59(Suppl 1):S103-S106
Bartter syndrome (BS) is an inherited renal tubular disorder characterized by low or normal blood pressure, hypokalemic metabolic alkalosis, and hyperreninemic hyperaldosteronism. Type III BS is caused by loss-of-function mutations in CLCNKB encoding basolateral ClC-Kb. The clinical phenotype of patients with CLCNKB mutations has been known to be highly variable, and cases that are difficult to categorize as type III BS or other hereditary tubulopathies, such as Gitelman syndrome, have been rarely reported. We report a case of a 10-year-old Korean boy with atypical clinical findings caused by a novel CLCNKB mutation. The boy showed intermittent muscle cramps with laboratory findings of hypokalemia, severe hypomagnesemia, and nephrocalcinosis. These findings were not fully compatible with those observed in cases of BS or Gitelman syndrome. The CLCNKB mutation analysis revealed a heterozygous c.139G>A transition in exon 13 [p.Gly(GGG)465Glu(GAG)]. This change is not a known mutation; however, the clinical findings and in silico prediction results indicated that it is the underlying cause of his presentation.
Alkalosis
;
Bartter Syndrome
;
Blood Pressure
;
Child
;
Computer Simulation
;
Exons
;
Gitelman Syndrome
;
Humans
;
Hyperaldosteronism
;
Hypokalemia
;
Male
;
Muscle Cramp
;
Nephrocalcinosis
;
Phenotype*
10.A Reinforced Endotracheal Tube Completely Severed by a Patient Bite and Lodged in the Right Main Bronchus
Susie YOON ; Hyunjung CHOO ; Se Eun KIM ; Heeyeon KWON ; Hannah LEE
The Korean Journal of Critical Care Medicine 2017;32(1):70-73
Reinforced endotracheal tubes (ETTs) are designed to resist kinking or compression. However, these have a potential risk of being obstructed or severed by a patient's bite. We report a case in which a reinforced ETT was severed by tube-bite while the patient was in the prone position during an intensive care unit stay. Bronchoscopic evaluation showed that the severed distal part of the tube had lodged in the patient's right main bronchus, and it had to be surgically removed. The patency of reinforced ETTs should be carefully monitored in patients intubated in the prone position.
Airway Obstruction
;
Bronchi
;
Bronchoscopy
;
Humans
;
Intensive Care Units
;
Intubation
;
Patient Rights
;
Prone Position